WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.
Find important updates, industry news, and information on CLSI’s upcoming events. Check out past CLSI press releases, upcoming Committees Week, and newsworthy items.
November 2, 2021
Glen Fine, the Chief Executive Officer of the Clinical and Laboratory Standards Institute (CLSI), announced he’s retiring effective Spring 2022. For 17 years Fine has served as the head of the globally recognized standards development organization in the field of laboratory medicine.
Read More
October 19, 2021
The Clinical and Laboratory Standards Institute (CLSI) has published the first edition of MM24—Molecular Methods for Genotyping and Strain Typing of Infectious Organisms.
Read More
September 28, 2021
The Clinical and Laboratory Standards Institute (CLSI) has published the first edition of NBS09— Newborn Screening for X-Linked Adrenoleukodystrophy.
Read More
June 11, 2021
The Clinical and Laboratory Standards Institute (CLSI) has published the first edition of C64—Quantitative Measurement of Proteins and Peptides by Mass Spectrometry. C64 provides a framework for developing clinical protein and peptide assays from conception to validation and is intended for those who have experience with traditional small-molecule liquid chromatography–mass spectrometry (LC-MS) but not with protein and peptide analysis.
Read More
May 10, 2021
The Clinical and Laboratory Standards Institute (CLSI) has published the first edition of QMS26—Managing Laboratory Records. QMS26 is intended to help laboratories meet quality management system requirements for the records portion of quality system essential documents and records management. It presents recommendations for developing a records management program, including designing, creating, reviewing, retaining, and disposing of laboratory records.
Read More
April 29, 2021
The Clinical and Laboratory Standards Institute (CLSI) has published the 7th edition of NBS01—Dried Blood Spot Specimen Collection for Newborn Screening. NBS01 provides descriptive, stepwise processes and procedures for collecting blood spot specimens for newborn screening. This standard was developed and continues to be updated to promote uniform practices for demographic newborn data and specimen collection. An expanded appendix section provides additional images and descriptions of unacceptable blood spot specimens.
Read More
March 29, 2021
The tables presented in M100 represent the most current information for drug selection, interpretation, and quality control using the procedures standardized in M02, M07, and M11. Users should replace previously published tables with these new tables
Read More
January 28, 2021
The Clinical and Laboratory Standards Institute (CLSI) has published the fourth edition of VET02— Development of Quality Control Ranges, Breakpoints, and Interpretive Categories for Antimicrobial Agents Used in Veterinary Medicine.
Read More
January 18, 2021
The Clinical and Laboratory Standards Institute (CLSI) has published the second edition of M54—Principles and Procedures for Detection and Culture of Fungi in Clinical Specimens. This guideline describes recommended processes for plating and examining fungal cultures as well as principles and procedures for the direct detection of fungi in clinical specimens, including criteria for performing and interpreting direct microscopic examinations. Safety considerations unique to mycology laboratories and a discussion of appropriate levels of laboratory service (eg, when to refer samples to more experienced laboratories) are highlighted.
Read More